Vivimed Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve (1) Un-audited Financial Results ....
VIVIMEDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivimed Labs has scheduled a board meeting on 13th August 2025 in Hyderabad to consider and approve its un-audited standalone and consolidated financial results for the quarter ended 30th June 2025 (Q1 FY26). The board will also take up the Board Report, the Annual General Meeting for FY2025, and related matters. A key item on the agenda is a proposal to raise funds through the issuance of equity shares, convertible bonds, debentures, warrants, preference shares, or other equity-linked securities. The proposed fund raise may be carried out via private placement, preferential issue, qualified institutions placement (QIP), or any other mode permitted under Indian law, subject to shareholder and regulatory approvals. The trading window for designated persons including directors is closed from 1st July 2025 until 48 hours after the Q1 results are declared.
Short-term: The stock may see volatility around 13th August as Q1 FY26 numbers are released and the fund-raising plan is discussed. Medium-term: The proposed equity or equity-linked securities issuance could lead to dilution of existing shareholders if approved, depending on the size and pricing of the raise.